Auxly Cannabis Valuation
| XLY Stock | CAD 0.03 0.01 14.29% |
Auxly Cannabis seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Auxly Cannabis Group from analyzing the firm fundamentals such as Return On Equity of -0.52, current valuation of 90.14 M, and Profit Margin of (0.41) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Auxly Cannabis' valuation include:
Price Book 0.3373 | Enterprise Value 90.1 M | Enterprise Value Ebitda 78.3339 | Price Sales 0.3516 | Enterprise Value Revenue 0.7865 |
Fairly Valued
Today
Please note that Auxly Cannabis' price fluctuation is out of control at this time. Calculation of the real value of Auxly Cannabis Group is based on 3 months time horizon. Increasing Auxly Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Auxly Cannabis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Auxly Stock. However, Auxly Cannabis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.03 | Real 0.0294 | Hype 0.03 |
The intrinsic value of Auxly Cannabis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Auxly Cannabis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Auxly Cannabis Group helps investors to forecast how Auxly stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Auxly Cannabis more accurately as focusing exclusively on Auxly Cannabis' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Auxly Cannabis' intrinsic value based on its ongoing forecasts of Auxly Cannabis' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Auxly Cannabis' closest peers.
Auxly Cannabis Cash |
|
Auxly Valuation Trend
Knowing Auxly Cannabis' actual value is paramount for traders when making sound investment determinations. Using both Auxly Cannabis' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Auxly Cannabis Total Value Analysis
Auxly Cannabis Group is at this time anticipated to have takeover price of 90.14 M with market capitalization of 38.52 M, debt of 159.04 M, and cash on hands of 14.64 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Auxly Cannabis fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
90.14 M | 38.52 M | 159.04 M | 14.64 M |
Auxly Cannabis Investor Information
About 22.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.34. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Auxly Cannabis Group recorded a loss per share of 0.07. The entity had not issued any dividends in recent years. The firm had 3:1 split on the 10th of April 2017. Based on the key indicators related to Auxly Cannabis' liquidity, profitability, solvency, and operating efficiency, Auxly Cannabis Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Auxly Cannabis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Auxly Cannabis has an asset utilization ratio of 38.59 percent. This suggests that the Company is making C$0.39 for each dollar of assets. An increasing asset utilization means that Auxly Cannabis Group is more efficient with each dollar of assets it utilizes for everyday operations.Auxly Cannabis Ownership Allocation
Auxly Cannabis holds a total of 1.25 Billion outstanding shares. Auxly Cannabis Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Auxly Cannabis Profitability Analysis
The company reported the revenue of 101.08 M. Net Loss for the year was (44.51 M) with profit before overhead, payroll, taxes, and interest of 19.29 M.About Auxly Cannabis Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Auxly Cannabis Group. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Auxly Cannabis Group based exclusively on its fundamental and basic technical indicators. By analyzing Auxly Cannabis's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Auxly Cannabis's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Auxly Cannabis. We calculate exposure to Auxly Cannabis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Auxly Cannabis's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.9 M | -1.8 M | |
| Pretax Profit Margin | (0.47) | (0.50) | |
| Operating Profit Margin | (0.19) | (0.20) | |
| Net Loss | (0.44) | (0.46) | |
| Gross Profit Margin | 0.21 | 0.20 |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.